Results 11 to 20 of about 26,084 (258)

Priapism associated with methylphenidate: a case report

The Turkish Journal of Pediatrics, 2010
Priapism is a persistent unwanted erection that is not associated with sexual desire or sexual stimulation. Immediate diagnosis and treatment are essential for priapism; otherwise, it causes ischemia of cavernous tissues, which will result in ...
Nursu Cakin-Memik, Ozlem Yildiz, Sahika G Sişmanlar, Isik Karakaya, Belma Ağaoğlu   +4 more
doaj   +2 more sources

Differential effects of MDMA and methylphenidate on social cognition. [PDF]

, 2014
Social cognition is important in everyday-life social interactions. The social cognitive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and methylphenidate (both used for neuroenhancement and as party drugs) are largely unknown.
Liechti, ME, Boris B Quednow, Hysek, Cédric M., Molly J Crockett, Crockett, Molly, Schmid, Yasmin, Cédric M Hysek, Hysek, CM, Linda D Simmler, Crockett, MJ, Simmler, LD, Schmid, Y, Quednow, Boris B., Yasmin Schmid, Liechti, Matthias E., Quednow, BB, Simmler, Linda D., Matthias E Liechti, Crockett, Molly J.   +18 more
core   +1 more source

Methylphenidate use and school performance among primary school children: a descriptive study

BMC Psychiatry, 2017
Background There is no conclusive evidence that stimulants have beneficial effects on major associated outcome parameters, particularly school performance.
Jurjen van der Schans, Rukiye Çiçek, Sefike Vardar, Jens HJ Bos, Tjalling W de Vries, Pieter J Hoekstra, Eelko Hak   +6 more
doaj   +1 more source

Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder

Frontiers in Behavioral Neuroscience, 2022
BackgroundDespite widespread use of stimulants to treat ADHD, individual responses vary considerably and few predictors of response have been identified.
Anne B. Arnett, Anne B. Arnett, Tara M. Rutter, Mark A. Stein, Mark A. Stein   +4 more
doaj   +1 more source

Methylphenidate treatment for cognitive symptoms associated with ADHD in a pediatric epilepsy patient following resection of a left frontal cortical dysplasia

Epilepsy & Behavior Reports, 2021
We present data on a 10-year-old patient with drug-resistant epilepsy who was treated with methylphenidate for symptoms of attention deficit hyperactivity disorder (ADHD) that developed after she underwent surgical resection of a left frontal cortical ...
Donald J. Bearden, Sidra Shakil, David O'Banion, Kim E. Ono, Daniel L. Drane, David W. Loring, Daniel C. Tarquinio   +6 more
doaj   +1 more source

Stability of Methylphenidate under Various pH Conditions in the Presence or Absence of Gut Microbiota

Pharmaceuticals, 2021
Methylphenidate is one of the most widely used oral treatments for attention-deficit/hyperactivity disorder (ADHD). The drug is mainly absorbed in the small intestine and has low bioavailability.
Julia Aresti-Sanz, Markus Schwalbe, Rob Rodrigues Pereira, Hjalmar Permentier, Sahar El Aidy   +4 more
doaj   +1 more source

Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidate

, 2022
Serdexmethylphenidate (SDX) chloride (Cl) is a novel prodrug of d-methylphenidate (d-MPH). These studies evaluated the abuse potential of SDX Cl when administered orally, intranasally (IN), and intravenously (IV). Three randomized, double-blind, placebo-
Megan J. Shram (12761166), Jaroslaw Kanski (12761178), Sven Guenther (12761169), Travis C. Mickle (12761172), Bradley D. Vince (12761184), Lynn Webster (522409), Andrea Martin (12761181), Rene Braeckman (12761175), Debra Kelsh (5810297), Andrew C. Barrett (12761187), Beatrice Setnik (2796757)   +10 more
core   +1 more source

Prevalence of methylphenidate use by university students in Campos dos Goytacazes, RJ

Vértices, 2014
Methylphenidate is a central nervous system stimulant commonly prescribed for children with Attention Deficit Hyperactivity Disorder. The aim of this study was to identify the prevalence of methylphenidate users among college students, as well as the ...
Fernanda Fraga Pessanha, Jéssica da Silva Mota   +1 more
doaj   +1 more source

Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder [PDF]

, 2014
A secondary objective of this head-to-head study of lisdexamfetamine dimesylate (LDX) and atomoxetine (ATX) was to assess treatment response rates in children and adolescents with attention-deficit hyperactivity disorder (ADHD) and an inadequate response
Esther Cardo, Hodgkins, P, Dittmann, RW, Caballero, B, Beatriz Caballero, Cardo, E, Adeyi, Ben, Civil, R, Ben Adeyi, Anderson, CS, Civil, Richard, Colleen S. Anderson, Hodgkins, Paul, Cardo-Jalon, Esther, Coghill, DR, Nagy, Peter, Cardo, Esther, Richard Civil, David R. Coghill, Anderson, Colleen S., Adeyi, B, Coghill, David R., Dittmann, Ralf W., Peter Nagy, Nagy, P, Caballero, Beatriz, Ralf W. Dittmann, Paul Hodgkins   +27 more
core   +1 more source

Reward‐enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention‐deficit/hyperactivity disorder

Neuropsychopharmacology Reports, 2018
Aim Attention‐deficit/hyperactivity disorder is a heterogeneous neurobiological disorder that is characterized by inattention, impulsivity, and an increase in motor activity.
Soichiro Ide, Yuiko Ikekubo, Jennifer Hua, Yukio Takamatsu, George R. Uhl, Ichiro Sora, Kazutaka Ikeda   +6 more
doaj   +1 more source